Pullen Investment Management’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$973K Buy
49,257
+109
+0.2% +$2.74K 0.46% 75
2026
Q2
$1.41M Buy
49,148
+620
+1% +$19.7K 0.65% 62
2026
Q1
$1.53M Sell
48,528
-116
-0.2% -$3.66K 0.77% 55
2025
Q4
$1.43M Sell
48,644
-114
-0.2% -$3.17K 0.75% 52
2025
Q3
$1.23M Buy
48,758
+359
+0.7% +$8.75K 0.67% 59
2025
Q2
$1.16M Sell
48,399
-235
-0.5% -$5.45K 0.7% 57
2025
Q1
$1.11M Buy
+48,634
New +$1.17M 0.7% 56

Other funds holding RTO

Pullen Investment Management's RTO Position: Q3 2026 in Review

Pullen Investment Management increased its Rentokil (RTO) stake by 0.22% in Q3 2026, buying an estimated $2.74K and bringing the position to 49,257 shares worth $973K. The position accounts for 0.46% of the portfolio, ranked #75.

Pullen Investment Management first reported a position in RTO in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.53M in Q1 2026. 47 funds tracked by Wall St. Rank hold RTO as of Q3 2026.

  • Pullen Investment Management held 49,257 shares of Rentokil worth $973K as of Q3 2026.
  • Pullen Investment Management bought 109 Rentokil shares in Q3 2026, an estimated $2.74K.
  • Rentokil made up 0.46% of Pullen Investment Management's portfolio in Q3 2026, its #75 holding.
  • Pullen Investment Management first reported a position in Rentokil in Q1 2025 and has held it in 7 quarters since.
  • Pullen Investment Management's Rentokil position peaked at $1.53M in Q1 2026.
  • 47 funds tracked by Wall St. Rank held Rentokil as of Q3 2026.

Based on Pullen Investment Management's 13F filing for Q3 2026, filed 23 Oct 2026.